期刊
TUBERCULOSIS
卷 94, 期 2, 页码 105-110出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.tube.2013.11.003
关键词
Pre-clinical; Vaccine; Efficacy; Clinical; MVA85A
资金
- Wellcome Trust [095780] Funding Source: Medline
There is an urgent need for an improved TB vaccine. Vaccine development is hindered by the lack of immune correlates and uncertain predictive value of preclinical animal models. As data become available from human efficacy trials, there is an opportunity to evaluate the predictive value of the criteria used to select candidate vaccines. Here we review the efficacy in animal models of the MVA85A candidate vaccine in light of recent human efficacy data and propose refinements to the preclinical models with the aim of increasing their predictive value for human efficacy. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据